The spectrum of systemic therapy and procedural approaches in the management of moderate to severe acne vulgaris: A review

Giornale Italiano di Dermatologia e Venereologia

Volumn 141, Issue 4, 2006, Pages 379-391

  Musumeci, M L ^a   Schlecht, K ^a   West, D P ^b   West, L E ^b   Innocenzi, D ^c   Micali, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acne, drug therapy; Dermatology; Skin diseases

Indexed keywords

ANTIANDROGEN; ANTIBIOTIC AGENT; AZITHROMYCIN; BUSERILIN; CHLORMADINONE ACETATE; CIMETIDINE; CLINDAMYCIN; CONTRACEPTIVE AGENT; CORTICOSTEROID; COTRIMOXAZOLE; CYPROTERONE ACETATE; DAPSONE; DOXYCYCLINE; DROSPIRENONE; ERYTHROMYCIN; ESTROGEN; ETHINYLESTRADIOL; FLUTAMIDE; GONADORELIN AGONIST; HORMONE; ISOTRETINOIN; KETOCONAZOLE; LEUPRORELIN; LYMECYCLINE; MINOCYCLINE; NAFARELIN; ROXITHROMYCIN; SPIRONOLACTONE; TETRACYCLINE; UNCLASSIFIED DRUG; ZINC;

ABDOMINAL PAIN; ACNE VULGARIS; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ALLERGY; ALOPECIA; ANOREXIA; ANOSMIA; ARTHRALGIA; BLOOD DYSCRASIA; BREAST TENDERNESS; CHEILITIS; CHLOASMA; CHOLESTATIC HEPATITIS; CLINICAL TRIAL; CRYOTHERAPY; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DISTRESS SYNDROME; ESOPHAGITIS; EXFOLIATIVE DERMATITIS; FLUID RETENTION; GASTROINTESTINAL DISEASE; HEPATOMEGALY; HERBAL MEDICINE; HORMONAL THERAPY; HUMAN; HYPERKALEMIA; HYPERPIGMENTATION; HYPERTHERMIC THERAPY; LEG EDEMA; LEUKEMOID REACTION; LIVER TOXICITY; LUPUS ERYTHEMATOSUS; MENSTRUATION DISORDER; MOOD CHANGE; MUSCLE STIFFNESS; NAUSEA AND VOMITING; NEPHROTOXICITY; OTOTOXICITY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTHERAPY; PSEUDOMEMBRANOUS COLITIS; RASH; REVIEW; SEBORRHEA; SERUM SICKNESS; SIDE EFFECT; SKIN EXFOLIATION; STEVENS JOHNSON SYNDROME; SYSTEMIC THERAPY; TOOTH DISCOLORATION; UNSPECIFIED SIDE EFFECT;

EID: 33749486762     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Zouboulis CC, Piquero-Martin J. Update of future of systemic acne treatment. Dermatolology 2003;206:37-53.
2. Kawada A, Aragane Y, Tezuka T. Levofloxacin is effective for inflammatory acne and achieves high levels in the lesions: An open study. Dermatology 2002;204:301-2.
3. Miller DM, Helms SE, Brodell RT. A practical approach to antibiotic treatment in women taking oral contraceptives. J Am Acad Dermatol 1994;30:1008-11.
4. Meynadier J, Alirezai M. Systemic antibiotics for acne. Dermatology 1998;196:135-9.
5. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple nonantimicrobial mechanisms. Adv Dent Res 1998;12:12-26.
6. Sadick NS. Antibiotics: unapproved uses or indications. Clin Dermatol 2000;19:11-6.
7. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ et al. Management of acne, a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003;49:S1-S37.
8. Skidmore R, Kovach R, Walker C, Thomas J, Bradshaw M, Leyden J et al. Effects of Subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003;139:459-64.
9. Biller JA, Flores A, Buie T, Mazpr S, Katz AJ. Tetracycline-induced esophagitis in adolescent patients. J Pediatr 1992;120:144-5.
10. Pierog SH, AL Salihi FL, Cinotti D. Pseudotumor cerebri-A complication of tetracycline treatment of acne. J Adolesc Health Care 1986;7:139-40.
11. Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline - A dose-related phenomenon. Clin Exp Dermatol 1993;18:425-27.
12. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003;148:467-78.
13. th ed. New York: McGraw-Hill, 1999.
14. Tzianetas I, Habal F, Keystone JS. Short report: severe hiccups secondary to doxycycline-induced esophagitis during treatment of malaria. Am J Trop Med Hyg 1996;54:203-4.
15. Chosidow O, Poli F, Nataline E, Advenier C, Revuz J. Comedonal diffusion of minocycline in acne. Dermatology 1998;196:162.
16. Grasset L, Guy C, Ollagnier M. Cyclines and acne: pay attention to adverse drug reactions! A recent literature review. Rev Med Interne 2003;24:305-16.
17. Cohen PR. Medication-associated depersonalization symptoms: report of transient depersonalization symptoms induced by minocycline. South Med J 2004;97:70-3.
18. Mouton RW, Joordan HF, Schneider JW. A new type of minocycline-induced cutaneous hyperpigmentation. Clin Exp Dermatol 2004;29: 8-14.
19. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997;133: 1224-30.
20. Pierard-Franchimont C, Goffin V, Arrese JE, Martalo O, Braham C, Slachmuylders P et al. Lymecycline and minocycline in inflammatory acne: A randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy. Skin Pharmacol Appl Skin Physiol 2002;15:112-9.
21. Eady EA. Bacterial resistance in acne. Dermatology 1998;196: 59-66.
22. Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: a world wide problem. Dermatology 2003;206:54-6.
23. Gammon WR, Meyer C, Lantis S, Shenefelt P, Reizner G, Cripps DJ. Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. J Am Acad Dermatol 1986;14:183-6.
24. Gantz NM, Zawacki JK, Dickerson WJ. Pseudomembraneous colitis associated with erythromycin. Ann Intern Med 1979;91:866-7.
25. May EF, Calvert PC. Aggravation of myasthenia gravis by erythromycin. Ann Neurol 1990;28:577-9.
26. Fernandez-Obregon AC. Azithromycin for the treatment of acne. Int J Dermatol 1997;36:239-40.
27. Caputo R, Barbareschi M, Veraldi S. Azithromycin for the systemic treatment of inflammatory acneic lesions: an open study. G It Dermatol Venereol 2003;138:327-31.
28. Parsad D, Pandhi R, Nagpal R, Negi KS. Azithromycin monthly pulse vs daily doxycycline in the treatment of acne vulgaris. J Dermatol 2001;28:1-4.
29. Kus S, Yucelten D, Aytug A. Comparison of efficacy of azithromycin vs doxycycline in the treatment of acne vulgaris. Clin Exp Dermatol 2005;30:215-20.
30. Akamatsu H, Horio T. Concentration of roxithromycin in the lesions of acne vulgaris. J Int Med Res 2001;29:537-40.
31. Chen Q, Koga T, Uchi H, Hara H, Terao H, Moroi Y et al. Propionibacterium acnes-induced IL-8 production may be mediated by NF-kappaB activation in human monocytes. J Dermatol Sci 2002;29:97-103.
32. Akamatsu H, Tomita T, Horio T. Effects of roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes. Dermatology 2002;204:277-80.
33. Inui S, Nakajima T, Fukuzato Y, Fujimoto N, Chang C, Yoshikawa K et al. Potential antiandrogenic activity of roxithromycin in skin. J Dermatol Sci 2001;27:147-51.
34. Ferahbas A, Utas S, Aykol D, Borlu M, Uksal U. Clinical evaluation of roxithromycin: a double-blind, placebo-controlled and crossover trial in patients with acne vulgaris. J Dermatol 2004;31:6-9.
35. Parsad D, Pandhi R, Dogra S. A guide to selection and appropriate use of macrolides in skin infections. Am J Clin Dermatol 2003;4: 389-97.
36. Nordin K, Hallander H, Fredriksson T, Rylander C. A clinical and bacteriological evaluation of the effect of sulphamethoxazole-trimethoprim in acne vulgaris resistant to prior therapy with tetracyclines. Dermatologica 1978:157:245-53.
37. Leyden JJ, Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol 2001;15(suppl 3):51-5.
38. Bottomley WW, Cunliffe WJ. Oral, thrimethoprim as a third-line antibiotic in the management of acne vulgaris. Dermatology 1993;187:193-6.
39. Schwarz RH. Considerations of antibiotic therapy during pregnancy. Obstet Gynecol 1981; 58(suppl):95S-99S.
40. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 2003;49(Suppl 3): S200-10.
41. Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol 2005;15:152-5.
42. Tham SN, Kwok YK. Cross-reactivity in fixed drug eruptions to tetracyclines. Arch Dermatol 1996;132:1134-5.
43. Eady EA, Jones CE, Gardner KJ, Taylor JP, Cove JH, Cunliffe WJ. Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Br J Dermatol 1993;39:1-32.
44. Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol 2001;144:339-46.
45. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the european union. Lancet 2001;357:1851-3.
46. Noble WC, Naidoo J. Evolution of antibiotic resistance in Staphylococcus aureus: The role of the skin. Br J Dermatol 1978;98:481-9.
47. Tan HH. Antibacterial therapy for acne: a guide to selection and use of systemic agents. Am J Clin Dermatol 2003;4:307-14.
48. Tan AW, Tan HH. Acne vulgaris: a review of antibiotic therapy. Expert Opin Pharmacother 2005;6:409-18.
49. Chivot M. Retinoid therapy for acne. A comparative review. Am J Clin Dermatol 2005;6:13-9.
50. http://www.emea.eu.int/
51. Meigel WN. How safe is oral isotretinoin? Dermatology 1997;195(Suppl 1):22-8.
52. Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation versus a standard formulation of isotretionin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol 2001
53. Mitchell AA, Van Bennekom CM, Louik C. A pregnancy-prevention program in women of childbearing age receiving isotretionin. N Engl J Med 1995;333:101-6.
54. Newton JN. How cost-effective is oral isotretinoin? Dermatology 1997;195(Suppl 1):10-4.
55. Kapp P, Bely M, Nemesanszly E. Ultrastructural findings in the liver due to long-term retinol (isotretinoin) treatment. Significance of the perisinusoidal (Ito) cells. Orv Hetil 2004;145:173-9.
56. Altman RS, Altman LJ, Altman JS. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris. Dermatology 2002;204:232-5.
57. Bremner JD, Fani N, Ashraf A, Votaw JR, Brummer ME, Cummins T et al. Functional brain imaging alterations in acne patients treated with isotretinoin. Am J Psychiatry 2005;162:983-91.
58. Chia CY, Lane W, Chibnall J, Allen A, Siegfried E. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne. Arch Dermatol 2005;141:557-60.
59. Sawaya ME, Hordinsky MK. The antiandrogens: when and how they should be used. Dermatol Clin 1993;11:65-72.
60. van Vloten WA, van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R. The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis 2002;69(Suppl):2-15.
61. Tan J. Hormonal treatment of acne: review of current best evidence. J Cutan Med Surg 2004;8 Suppl 4:11-5.
62. Goodfellow A, Alaghband-Zadeh J, Carter G, Cream JJ, Holland S, Scully J et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol 1984;111:209-14.
63. Longshore SJ, Hollandsworth K. Acne vulgaris: one treatment does not fit all. Cleve Clin J Med 2003;70:670-80.
64. Worret I, Arp W, Zahradnik HP, Andreas JO, Binder N. Acne resolution rate: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon). Dermatology 2001;103:38-44.
65. Cusan L, Dupont A, Belanger A, Tremblay RR, Labrie F. Treatment of hirsutism with the pure antiandrogen flutamide. J Am Acad Dermatol 1990;23:462-9.
66. th ed. New York: McGraw-Hill, 2005.
67. Wysowski D, Freiman J, Tourtelot J, Horton M. Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med 1993;118:860-4.
68. Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen intensitivity. J Clin Endocrinol Metab 1993;76:524-8.
69. Shaw JC. Antiandrogen and hormonal treatment of acne. Dermatol Clin 1996;14:803-811.
70. Redmond GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM, Jorizzo JL. Norgestimate and ethinylestradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial. Obstet Gynecol 1997;89:615-22.
71. Thiboutot D, Chen W. Update and future of hormonal therapy in acne. Dermatolology 2003;206:57-67.
72. Kaminsky A. Less Common Methods to Treat Acne. Dermatology 2003;206:68-73.
73. Cunliffe WJ, Stables G. Optimal use of isotretinoin. J Cut Med Surg 1996;1:14-25.
74. Schmidt JB. Other antiandrogens. Dermatology 1998;196:153-7.
75. Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001;203:135-40.
76. Weimar VM, Puhl SC, Smith WH, tenBroeke JE. Zinc sulfate in acne vulgaris. Arch Dermatol 1978;114:1776-8.
77. Salzman MB, Smith EM, Koo C. Excessive oral zinc supplementation. J Pediatr Hematol Oncol 2002;24:582-4.
78. Gollnick HP, Krautheim A. Topical treatment in acne: current status and future aspects. Dermatology 2003;206:29.
79. Jordan RE, Cummins CL, Burls AJ, Seukeran DC. Laser resurfacing for facial acne scars. Cochrane Database Syst Rev 2004;(1):CD001866.
80. Hung VC, Lee JY, Zitelli JA, Hebda PA. Topical tretinoin and epithelial wound healing. Arch Dermatol 1989;125:65-9.
81. Ho C, Nguyen Q, Lowe NJ, Griffin ME, Lask G. Laser resurfacing in pigmented skin. Dermatol Surg 1995;21:1035-7.
82. Bradley DT, Park SS. Scar revision via resurfacing. Facial Plastic Surgery 2001;17:253-61.
83. Szalay LV. Treatment of acne scarring by combined dermabrasion and chemical peel. Plast Reconstr Surg 1987;79:307-8.
84. Pugliese PT. The skin's antioxidant systems. Dermatol Nurs 1998;10:401-16.
85. Davies MG, Marks R. Studies on the effect of salicylic acid on normal skin. Br J Dermatol 1976;95:187-92.
86. Wiest L. Chemical peels in aesthetic dermatology. Hautarzt 2004;55:611-20.
87. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000;115:183-92.
88. West TB. Laser resurfacing of atrophic scars. Dermatol Clin 1997;15: 449-57.
89. Weinstein C. Computerized scanning erbium: YAG laser for skin resurfacing. Dermatol Surg 1998;24:83-9.
90. Nehal KS, Levine VJ, Ross B, Ashinoff R. Comparison of high-energy pulsed carbon dioxide laser resurfacing and dermabrasion in the revision of surgical scars. Dermatol Surg 1998;24:647-50.
91. Bernstein LJ, Kauvar AN, Grossman MC, Geronemus RG. Scar resurfacing with high-energy, short pulsed and flashscanning carbon dioxide lasers. Dermatol Surg 1998;24:101-7.
92. Morton CA, Scholefield RD, Whitehurst C, Birch J. An open study to determine the efficacy of blue light in the treatment of mild to moderate acne. J Dermatolog Treat 2005;16:219-23.
93. Young S, Bolton P, Dyson M, Harvey W, Diamantopoulos Cc. Macrophage responsiveness to light therapy. Lasers Surg Med 1989;9:497-505.
94. Szpringer E, Lutnicki K, Marciniak A. Photodynamic therapy-mechanism and employment. Ann Univ Mariae Curie Sklodowska 2004;59:498-502.
95. Santos MA, Belo VG, Santos G. Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: comparative study. Dermatol Surg 2005;31:910-5.
96. Ruiz-Esparza J, Gomez JB. Nonablative radiofrequency for active acne vulgaris: the use of deep dermal heat in the treatment of moderate to severe active acne vulgaris (thermotherapy): a report of 22 patients. Dermatol Surg 2003;29:333-9.
97. Graham GF. Cryotherapy against acne vulgaris yields good to excellent results. Dermatol Prac 1972;5:13-5.
98. Levine RM, Rasmussen JE. Intralesional corticosteroid in the treatment of nodulocystic acne Arch dermatol 1983;119:480-1.
99. Martin KW, Ernst E. Herbal medicine for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother 2003;51:241-6.
100. Dattner AM. From medical herbalism to phytotherapy in dermatology: back to the future. Dermatol Ther 2003;16:106-13.
101. Fung HT, Fung CW, Kam CW. Lead poisoning after ingestion of home-made Chinese medicines. Emerg Med 2004;15:518-20.